Angelica Sinensis Polysaccharide Induces Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells
Authors:
- Rong JiangRJRong Jiang
- Shu-Dan SongSSShu-Dan Song
- Zi-Sen HuaZHZi-Sen Hua
- Jian-Wei WangJWJian-Wei Wang
- Ya-Ping WangYWYa-Ping Wang
Open Access
- 18 May 2015
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (9) , 3715-3721
Abstract
Angelica Sinensis Polysaccharide Induces Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells Angelica sinensis polysaccharides;K562;inducing differentiation;JAK2;STAT5; Leukemia is a clonal disorder with blocked normal differentiation and cell death of hematopoietic progenitor cells. Traditional modalities with most used radiation and chemotherapy are nonspecific and toxic which cause adverse effects on normal cells. Differentiation inducing therapy forcing malignant cells to undergo terminal differentiation has been proven to be a promising strategy. However, there is still scarce of potent differentiation inducing agents. We show here that Angelica sinensis polysaccharide (ASP), a major active component in Dong quai (Chinese Angelica sinensis), has potential differentiation inducing activity in human chronic erythro-megakaryoblastic leukemia K562 cells. MTT assays and flow cytometric analysis demonstrated that ASP inhibited K562 cell proliferation and arrested the cell cycle at the G0/G1 phase. ASP also triggered K562 cells to undergo erythroid differentiaton as revealed by morphological changes, intensive benzidine staining and hemoglobin colorimetric reaction, as well as increased expression of glycophorin A (GPA) protein. ASP induced redistribution of STAT5 protein from the cytoplasm to the nucleus. Western blotting analysis further identified that ASP markedly sensitized K562 cells to exogenous erythropoietin (EPO) by activating EPO-induced JAK2/STAT5 tyrosine phosphorylation, thus augmenting the EPO-mediated JAK2/STAT5 signaling pathway. On the basis of these findings, we propose that ASP might be developed as a potential candidate for chronic myelogenous leukemia inducing differentiation treatment.Keywords
This publication has 41 references indexed in Scilit:
- Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemiaBlood Cancer Journal, 2011
- A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathwayPhytomedicine, 2010
- Stat1 Nuclear Translocation by Nucleolin upon Monocyte DifferentiationPLOS ONE, 2009
- Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine ResponsesPLOS ONE, 2009
- Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity LevelsMolecular and Cellular Biology, 2008
- Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2Blood, 2008
- Hematopoietic cytokinesBlood, 2008
- STAT5 signaling in normal and pathologic hematopoiesisFrontiers in Bioscience-Landmark, 2007
- Biological Inhibitory Effects of the Chinese Herb Danggui on Brain AstrocytomaPathobiology, 2006
- The Antitumor Effects of Angelica sinensis on Malignant Brain Tumors In vitro and In vivoClinical Cancer Research, 2005